Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (51-60 of 415) with videos related to

Pageof 42
Sort By:
Journal of the International AIDS Society|November 14, 2014
Haemophagocytic syndrome and elevated EBV load as initial manifestation of Hodgkin lymphoma in a HIV patient: case report and review of the literatureDelphine Sculier, Thanh Doco-Lecompte, Mathieu Rougemont, et al.
HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settingsNathan Ford, Janice Lee, Isabelle Andrieux-Meyer, et al.
Journal of the International AIDS Society|March 29, 2011
Driving a decade of change: HIV/AIDS, patents and access to medicines for allEllen 't Hoen, Jonathan Berger, Alexandra Calmy, et al.
Antiviral Therapy|May 12, 2009
A new era of antiretroviral drug toxicityAlexandra Calmy, Bernard Hirschel, David A Cooper, et al.
Revue Medicale Suisse|January 14, 2021
[HIV in the time of COVID-19 : the meeting between two pandemics]Olivier Nawej Tshikung, Hélène Buvelot, Alexandra Calmy, et al.
Revue Medicale Suisse|February 1, 2023
[News in HIV infection, long-acting injectable treatments]Olivier Nawej Tshikung, Olivier Segeral, Matthias Cavassini, et al.
AIDS (London, England)|September 10, 2003
Highly active antiretroviral therapy in resource-poor settings: the experience of Médecins Sans FrontièresJean-Michel Tassie, Elisabeth Szumilin, Alexandra Calmy, et al.
Lancet (London, England)|July 10, 2007
Clinical update: adverse effects of antiretroviral therapyAlexandra Calmy, Bernard Hirschel, David A Cooper, et al.
AIDS (London, England)|May 9, 2021
Kaposi sarcoma in antiretroviral therapy-treated people with HIV: a wake-up call for research on human herpesvirus-8Léna Royston, Stéphane Isnard, Alexandra Calmy, et al.
AIDS (London, England)|June 27, 2008
Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans FrontièresMar Pujades-Rodríguez, Daniel O'Brien, Pierre Humblet, et al.
Pageof 42

Showing results (51-60 of 415) with videos related to

Sort By:
Pageof 42
Journal of the International AIDS Society|November 14, 2014
Haemophagocytic syndrome and elevated EBV load as initial manifestation of Hodgkin lymphoma in a HIV patient: case report and review of the literatureDelphine Sculier, Thanh Doco-Lecompte, Mathieu Rougemont, et al.
HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settingsNathan Ford, Janice Lee, Isabelle Andrieux-Meyer, et al.
Journal of the International AIDS Society|March 29, 2011
Driving a decade of change: HIV/AIDS, patents and access to medicines for allEllen 't Hoen, Jonathan Berger, Alexandra Calmy, et al.
Antiviral Therapy|May 12, 2009
A new era of antiretroviral drug toxicityAlexandra Calmy, Bernard Hirschel, David A Cooper, et al.
Revue Medicale Suisse|January 14, 2021
[HIV in the time of COVID-19 : the meeting between two pandemics]Olivier Nawej Tshikung, Hélène Buvelot, Alexandra Calmy, et al.
Revue Medicale Suisse|February 1, 2023
[News in HIV infection, long-acting injectable treatments]Olivier Nawej Tshikung, Olivier Segeral, Matthias Cavassini, et al.
AIDS (London, England)|September 10, 2003
Highly active antiretroviral therapy in resource-poor settings: the experience of Médecins Sans FrontièresJean-Michel Tassie, Elisabeth Szumilin, Alexandra Calmy, et al.
Lancet (London, England)|July 10, 2007
Clinical update: adverse effects of antiretroviral therapyAlexandra Calmy, Bernard Hirschel, David A Cooper, et al.
AIDS (London, England)|May 9, 2021
Kaposi sarcoma in antiretroviral therapy-treated people with HIV: a wake-up call for research on human herpesvirus-8Léna Royston, Stéphane Isnard, Alexandra Calmy, et al.
AIDS (London, England)|June 27, 2008
Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans FrontièresMar Pujades-Rodríguez, Daniel O'Brien, Pierre Humblet, et al.
Pageof 42